The Effectiveness of Direct Oral Anticoagulation in the Treatment of Left Ventricular Thrombus in Noncompaction Cardiomyopathy: A Case Report
Ossama Maadarani, Leila Bigdelu, Harikrishna Rajendran, Zouhair Bitar
TL;DR
This case report shows that direct oral anticoagulants can effectively treat a heart condition in a patient with noncompaction cardiomyopathy.
Contribution
This is the second reported case of successful LVT treatment in NCCM using DOACs.
Findings
DOACs led to complete resolution of left ventricular thrombus in a noncompaction cardiomyopathy patient.
This case supports the potential use of DOACs for treating LVT in NCCM.
There is limited evidence on DOACs for this specific condition.
Abstract
The use of direct oral anticoagulants (DOACs) in the treatment of left ventricular thrombus (LVT) associated with specific types of cardiomyopathy like noncompaction cardiomyopathy (NCCM) is not established. We report a case of LVT in an NCCM patient treated with DOAC with complete resolution. To the best of our knowledge, this is the second case of successful treatment of LVT related to NCCM with DOACs.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCardiomyopathy and Myosin Studies · Neurogenetic and Muscular Disorders Research · Cardiovascular Function and Risk Factors